Professional Documents
Culture Documents
PHARMACEUTICAL
INDUSTRY
A DYSFUNCTIONAL
RELATIONSHIP
A DYSFUNCTIONAL
RELATIONSHIP
239 US settlement payments amounting to $30.2b
have been paid
COI- 84% of doctors having a relationship with
pharmaceuticals.
ROADMAP
I.
Institutional Corruption
INSTITUTIONAL CORRUPTION
IMPROPER DEPENDENCIES
TRIAL METHODS
FDA depends on scientific data from
pharmaceuticals
PHARMACOVIGILANCE
Post clinical trial for adverse side effects.
Able to choose trial designs
Delay comparative studies
- Vioxx Gastrointestinal Outcomes
Research (VIGOR) & Weinblatt.
SOURCE OF
INFORMATION
Pharmaceutical physician relationship
Continual Medical Education (CME)Talks
Medical journals
Funding to sustain operations
Physician patient relationships
Information asymmetry more pronounced
No discretion Fiduciary duty
compromised
Exploit the unequal relationship- Incentives
to increase prescriptions.
GOVT REGULATION
Disproportionate influence over the entire
process.
Free market non-existent
Information asymmetries
Overdependencies
PPSA
Payments or transfers of value of more than
$10.
PPSA
Disclosure is of limited use
I.
REFORMS
FDA to conduct pharmacovigilance
Post trials
Separate funding for CME talks
THE END